Filing Details
- Accession Number:
- 0001209191-17-053466
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-20 16:28:04
- Reporting Period:
- 2017-09-18
- Accepted Time:
- 2017-09-20 16:28:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1596492 | Herve Hoppenot | 1801 Augustine Cut-Off Wilmington DE 19803 | Chairman / Ceo | Yes | Yes | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-09-18 | 70,502 | $119.45 | 299,004 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $117.70 - $120.73.
- Includes an aggregate of 252,916 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.